Market News AIOpen the app

ARX stock news · Accelerant Holdings

Stories about Accelerant Holdings (ARX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ARX

Follow Accelerant Holdings (ARX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ARX
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 6:43 PM ET · Opinion

    RBC Capital is keeping its hold rating on Accelerant Holdings, setting a price target of $20.25.

    Neutral

    RBC kept its Hold rating and $20.25 target for Accelerant. The update reports no change in the company's business, so it does not shift the outlook.

  2. Sep 23, 2026, 9:23 AM ET · Opinion

    An Autoliv analyst changed their mind and listed the five biggest downgrades for Wednesday.

    Bad for ARX

    Raymond James downgraded Accelerant to Underperform, which lowers sell-side support for the stock. Accelerant closed at $19.79 on Tuesday, near its recent high, but the downgrade still reduces positive analyst coverage.

  3. Sep 23, 2026, 8:41 AM ET · Deal

    Accelerant Holdings shares news about a planned merger and a vote for shareholders.

    Neutral

    Accelerant announced a proposed merger and upcoming proxy filing; read the definitive proxy and Schedule 13E-3 for deal price, timing and shareholder effects.

  4. Aug 13, 2026, 10:35 AM ET · Market

    On Thursday, significant upward movement observed in major stocks including Accelerant Holdings, CorMedix, and Birkenstock.

    Good for ARX

    Accelerant Holdings' stock jumped significantly after announcing its acquisition by Thoma Bravo and reporting strong second-quarter results, which has positively influenced other stocks in the market, including CorMedix and Birkenstock, both of which reported better-than-expected financial results.